2019冠状病毒病大流行与加拿大大麻使用-范围审查

Kelda Newport, Lisa Bishop, Jennifer Donnan, Shefali Pal, Maisam Najafizada
{"title":"2019冠状病毒病大流行与加拿大大麻使用-范围审查","authors":"Kelda Newport,&nbsp;Lisa Bishop,&nbsp;Jennifer Donnan,&nbsp;Shefali Pal,&nbsp;Maisam Najafizada","doi":"10.1186/s42238-023-00196-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Since the start of the COVID-19 pandemic in Canada, the cannabis industry has adapted to public health emergency orders which had direct and indirect consequences on cannabis consumption. The objective of this scoping review was to describe the patterns of consumption and cannabis-related health and safety considerations during the COVID-19 pandemic in Canada.</p><p><strong>Methods: </strong>For this scoping review, we searched four electronic databases supplemented with grey literature. Peer-reviewed or pre-print studies using any study design and grey literature reporting real-world data were included if published in English between March 2020 and September 2021 and focused on cannabis and COVID-19 in Canada. A content analysis was performed.</p><p><strong>Results: </strong>Twenty-one studies met the inclusion/exclusion criteria. Study designs included cross-sectional surveys (n = 17), ecological study (n = 1), conceptual paper (n = 1), longitudinal study (n = 1), and prospective cohort study (n = 1). Most were conducted solely in Canada (n = 18), and the remaining included global data. Our content analysis suggested that cannabis consumption during the pandemic varied by reasons for use, consumers' age, gender, and method of consumption. Health and safety impacts due to the COVID-19 pandemics included increased mental illness, increased emergency visits, and psychosocial impacts.</p><p><strong>Discussion: </strong>This scoping review suggested that the impact of the pandemic on cannabis consumption in Canada is more complex than simplistic assumptions of an increase or decrease in consumption and continues to be difficult to measure. This study has explored some of those complexities in relation to reasons for use, age, gender, method of consumption, and health impacts. This scoping review is limited by focusing on the breadth compared to depth.</p><p><strong>Conclusions: </strong>Legalizing nonmedical use of cannabis in Canada in 2018 has had its challenges of implementation, one of which has been the changing context of the society. The findings of this study can help inform cannabis policy updates in Canada as the country is reaching its fifth year of legalizing nonmedical use of cannabis.</p>","PeriodicalId":15172,"journal":{"name":"Journal of Cannabis Research","volume":"5 1","pages":"31"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388476/pdf/","citationCount":"0","resultStr":"{\"title\":\"The COVID-19 pandemic and cannabis use in Canada-a scoping review.\",\"authors\":\"Kelda Newport,&nbsp;Lisa Bishop,&nbsp;Jennifer Donnan,&nbsp;Shefali Pal,&nbsp;Maisam Najafizada\",\"doi\":\"10.1186/s42238-023-00196-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Since the start of the COVID-19 pandemic in Canada, the cannabis industry has adapted to public health emergency orders which had direct and indirect consequences on cannabis consumption. The objective of this scoping review was to describe the patterns of consumption and cannabis-related health and safety considerations during the COVID-19 pandemic in Canada.</p><p><strong>Methods: </strong>For this scoping review, we searched four electronic databases supplemented with grey literature. Peer-reviewed or pre-print studies using any study design and grey literature reporting real-world data were included if published in English between March 2020 and September 2021 and focused on cannabis and COVID-19 in Canada. A content analysis was performed.</p><p><strong>Results: </strong>Twenty-one studies met the inclusion/exclusion criteria. Study designs included cross-sectional surveys (n = 17), ecological study (n = 1), conceptual paper (n = 1), longitudinal study (n = 1), and prospective cohort study (n = 1). Most were conducted solely in Canada (n = 18), and the remaining included global data. Our content analysis suggested that cannabis consumption during the pandemic varied by reasons for use, consumers' age, gender, and method of consumption. Health and safety impacts due to the COVID-19 pandemics included increased mental illness, increased emergency visits, and psychosocial impacts.</p><p><strong>Discussion: </strong>This scoping review suggested that the impact of the pandemic on cannabis consumption in Canada is more complex than simplistic assumptions of an increase or decrease in consumption and continues to be difficult to measure. This study has explored some of those complexities in relation to reasons for use, age, gender, method of consumption, and health impacts. This scoping review is limited by focusing on the breadth compared to depth.</p><p><strong>Conclusions: </strong>Legalizing nonmedical use of cannabis in Canada in 2018 has had its challenges of implementation, one of which has been the changing context of the society. The findings of this study can help inform cannabis policy updates in Canada as the country is reaching its fifth year of legalizing nonmedical use of cannabis.</p>\",\"PeriodicalId\":15172,\"journal\":{\"name\":\"Journal of Cannabis Research\",\"volume\":\"5 1\",\"pages\":\"31\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388476/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cannabis Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s42238-023-00196-7\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cannabis Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s42238-023-00196-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:自2019冠状病毒病大流行在加拿大开始以来,大麻产业已经适应了对大麻消费产生直接和间接影响的公共卫生紧急命令。本次范围审查的目的是描述加拿大COVID-19大流行期间的消费模式以及与大麻相关的健康和安全考虑因素。方法:为了进行范围综述,我们检索了四个电子数据库,并辅以灰色文献。如果在2020年3月至2021年9月期间以英文发表,并以加拿大的大麻和COVID-19为重点,则包括使用任何研究设计和报告真实世界数据的同行评审或预印本研究和灰色文献。进行了内容分析。结果:21项研究符合纳入/排除标准。研究设计包括横断面调查(n = 17)、生态研究(n = 1)、概念研究(n = 1)、纵向研究(n = 1)和前瞻性队列研究(n = 1)。大多数研究仅在加拿大进行(n = 18),其余研究包括全球数据。我们的内容分析表明,大流行期间的大麻消费量因使用原因、消费者的年龄、性别和消费方法而异。COVID-19大流行对健康和安全的影响包括精神疾病增加、急诊人数增加以及心理社会影响。讨论:这一范围审查表明,这一流行病对加拿大大麻消费的影响比消费增加或减少的简单假设更为复杂,并且仍然难以衡量。本研究探讨了与使用原因、年龄、性别、消费方法和健康影响有关的一些复杂性。与深度相比,这个范围审查的重点是广度。结论:2018年加拿大大麻非医疗使用合法化面临着实施挑战,其中之一是社会背景的变化。这项研究的结果可以帮助为加拿大的大麻政策更新提供信息,因为该国正在进入大麻非医疗使用合法化的第五个年头。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

The COVID-19 pandemic and cannabis use in Canada-a scoping review.

The COVID-19 pandemic and cannabis use in Canada-a scoping review.

Background: Since the start of the COVID-19 pandemic in Canada, the cannabis industry has adapted to public health emergency orders which had direct and indirect consequences on cannabis consumption. The objective of this scoping review was to describe the patterns of consumption and cannabis-related health and safety considerations during the COVID-19 pandemic in Canada.

Methods: For this scoping review, we searched four electronic databases supplemented with grey literature. Peer-reviewed or pre-print studies using any study design and grey literature reporting real-world data were included if published in English between March 2020 and September 2021 and focused on cannabis and COVID-19 in Canada. A content analysis was performed.

Results: Twenty-one studies met the inclusion/exclusion criteria. Study designs included cross-sectional surveys (n = 17), ecological study (n = 1), conceptual paper (n = 1), longitudinal study (n = 1), and prospective cohort study (n = 1). Most were conducted solely in Canada (n = 18), and the remaining included global data. Our content analysis suggested that cannabis consumption during the pandemic varied by reasons for use, consumers' age, gender, and method of consumption. Health and safety impacts due to the COVID-19 pandemics included increased mental illness, increased emergency visits, and psychosocial impacts.

Discussion: This scoping review suggested that the impact of the pandemic on cannabis consumption in Canada is more complex than simplistic assumptions of an increase or decrease in consumption and continues to be difficult to measure. This study has explored some of those complexities in relation to reasons for use, age, gender, method of consumption, and health impacts. This scoping review is limited by focusing on the breadth compared to depth.

Conclusions: Legalizing nonmedical use of cannabis in Canada in 2018 has had its challenges of implementation, one of which has been the changing context of the society. The findings of this study can help inform cannabis policy updates in Canada as the country is reaching its fifth year of legalizing nonmedical use of cannabis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信